Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-06-2020 | Ulcerative Colitis | Case report

Dasatinib/imatinib

Ulcerative colitis: case report

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Peng Y, et al. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis with Uncertain Etiology in the Context of Chronic Myeloid Leukemia. Inflammatory Bowel Diseases 26: E26-E27, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1093/ibd/izaa016 Peng Y, et al. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis with Uncertain Etiology in the Context of Chronic Myeloid Leukemia. Inflammatory Bowel Diseases 26: E26-E27, No. 4, Apr 2020. Available from: URL: http://​doi.​org/​10.​1093/​ibd/​izaa016
Metadata
Title
Dasatinib/imatinib
Ulcerative colitis: case report
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79884-0

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Imatinib

Case report

Disulfiram